Out of Pocket Pain Survey Sharpens Focus on Costs
When we decided to look at out of pocket costs we wanted to get a better understanding of how much people pay, who pays and what impact these costs have on their healthcare and their lives. We asked people to give us their story as well as giving us some basic information through the survey. The...
If we consider what defines patient-centred care: “health care that is respectful of, and responsive to, the preferences, needs and values of patients and consumers”, then without patient input, we are left to assume that we understand what they need and value in health care. Read the rest of...
These slides accompanied Leanne Wells' speech at the 4th International Health Reform Conference.
This webinar, co-hosted with the AHHA, heard Chris Pointon talk about the #hellomynameis movement, compassionate care and what this means to patients, carers and health care staff. View a recording here: https://youtu.be/bK5_um6StgQ.
CHF appreciates the opportunity to provide a submission in response to the Australian Commission on Safety and Quality in Health Care (ACSQHC) on Patient Safety and Quality Improvement in Primary Care Consultation Paper. At the heart of CHF’s policy agenda is patient-centred care. Our responses...
Presenting options for regulatory reforms to make a positive contribution to reducing the misuse and abuse of strong opioids and contributing to better pain management for consumers.
CHF is pleased to make a submission to the consultation on early release of superannuation benefits under compassionate and financial hardship grounds and for victims of crime compensation. CHF’s interest in this issue is related to ensuring Australians have affordable access to the health...
These slides were using in the codeine webinar delivered by Policy Manager, Jo Root and CEO of PainAustralia, Carol Bennett in January 2018. A recording of the webinar can be viewed here: https://youtu.be/1sX3gSFG-UU
We welcome the opportunity to make this submission in response to the consultation paper on proposed regulatory changes related to personalised and 3D printed medical devices released by the Therapeutic Goods Administration (TGA) in November 2017.
New manufacturing technologies present...